Cimetidine Hydrochloride Solution
Product Images NDC 0121-1025

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cimetidine Hydrochloride (NDC 0121-1025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cimetidine Os 1)

Chemical Structure (Cimetidine Os 1)
Chemical structure of Cimetidine Hydrochloride, showing the arrangement of its atoms and bonds as part of its molecular formula.*
FDA Label Image

Table1 (Cimetidine Os 2)

Table1 (Cimetidine Os 2)
This table presents inhibitory effects on Cimetidine. It lists stimulants (Betazole, Pentagastrin, Caffeine, Insulin) with their doses, corresponding Cimetidine doses (300 mg oral or 100 mg/hr intravenous), and the percentage of inhibition with respective times.*
FDA Label Image

Table 2 (Cimetidine Os 3)

Table 2 (Cimetidine Os 3)
A data table titled 'Duodenal Ulcer Healing Rates With Various Oral Cimetidine Dosage Regimens' showing healing percentages at weeks 4, 6, and 8 for four dosage regimens: 300 mg q.i.d., 400 mg b.i.d., 800 mg h.s., and 1600 mg h.s., with percentages ranging from 68% to 94%, and a note that data are averages from controlled clinical trials.*
FDA Label Image

Table 3 (Cimetidine Os 4)

Table 3 (Cimetidine Os 4)
A data table comparing healing rates of Cimetidine and Placebo at week 2 and total at week 6, including results from a multicenter U.S. study for an 800 mg oral regimen. The table shows percentages and counts, with statistical significance indicated.*
FDA Label Image

Table 4 (Cimetidine Os 5)

Table 4 (Cimetidine Os 5)
A data table comparing the percentage outcomes at weeks 6 and 12 for Cimetidine at dosages of 800 mg twice daily and 400 mg once daily versus placebo in two clinical trials. The table includes p-values for the statistical significance of 800 mg twice daily compared to placebo.*
FDA Label Image

Cimetidine Hydrochloride Oral Solution (Cimetidine Os 6)

Cimetidine Hydrochloride Oral Solution (Cimetidine Os 6)
Label for Cimetidine Hydrochloride Oral Solution 300 mg/5 mL distributed by PAI Pharma. The label includes dosing information, alcohol content (2.8%), storage conditions, and a barcode. The bottle size is 8 fl oz (237 mL). The label features the PAI Pharma logo and specifies it is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.